COMP <GO>
KRYS vs PCVX // EV/EBITDA & P/E VALUATION
Krystal Biotech Inc. (NASDAQ) VS. Vaxcyte Inc. (NASDAQ) • 15-METRIC TALLY: KRYS 7
— PCVX 4
■ METRIC PARITY
LAST: $332.29 (+2.38%) • MKT CAP: $9.61B
valuation
53.4x
LAST: $62.03 (-0.93%) • MKT CAP: $9.85B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRYS VS. PCVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KRYS | PCVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.50% | -27.60% | +44.10 | KRYS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 53.4x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.97% | -6.79% | +8.76 | KRYS | /fcf-yield <GO> |
| Operating Margin | 41.50% | -33.50% | +75.00 | KRYS | /operating-margins <GO> |
| Net Profit Margin | 52.60% | 0.00% | +52.60 | KRYS | /net-margins <GO> |
| Revenue Growth (YoY) | 33.90% | 19.80% | +14.10 | KRYS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 18.11 | +7.89 | KRYS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | KRYS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.2 | 50.1 | -1.90 | PCVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.07 | -0.16 | PCVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.4x | 23.0x | +16.40 | PCVX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.61B | $9.85B | -$247.9M | PCVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KRYS REV | PCVX REV | KRYS GROSS % | PCVX GROSS % | KRYS FCF | PCVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $389.1M | $0 | — | — | $188.9M | -$669.3M |
| FY 2024 | $290.5M | $0 | — | — | $119.2M | -$475.1M |
| FY 2023 | $50.7M | $0 | — | — | -$91.1M | -$296.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRYS // BETA 0.91
PCVX // BETA 1.07